New drug approved for treatment of Lipodystropy in HIV patients caused by antiretroviral drugs.
US FDA has approved drug Egrifta (Tesamorelin) for treating antiretroviral drugs associated lipodystrophy in HIV positive patients, lipodystrophy a condition of abnormal lipid metabolism that result in loss subcutaneous of fat on face , legs and buttocks, and accumulation of fat on abdomen , liver, stomach, and other abdominal organs resulting in abdominal obesity and fat deposition in their upper backs and chest. Lipodystrophy in HIV patients affects the health and quality of life.
Lipodystrophy in HIV positive patients is attributed to use of antiretroviral drugs belonging to class protease inhibitors and nucleoside reverse transcriptase inhibitors.Drug Egrifta (Tesamorelin) is now a first US FDA approved drug available for treatment of lipodystrophy in HIV positive patients associated with antiretroviral drugs.
Drug Egrifta (Tesamorelin) is a growth hormone releasing factor (GRF) drug which is required to be administered as injection once in a day.Drug Egrifta’s (Tesamorelin) safety and efficacy was evaluated in two clinical trials which included 816 HIV positive adult men and women with lipodystrophy and excess abdominal fat.
Out of 543 patients who received Egrifta for 26 weeks , placebo controlled period in bot studies it was observed that patients taking drug Egrifta (Tesamorelin) show reduction in abdominal fat measured by CT scan , compared to patients on placebo. Cardiovascular benefits of Egrifta if it reduces the risk of cardiovascular disease or it improves compliance with antiretroviral drugs are yet to be studied.
Side effects of Drug Egrifta (Tesamorelin) reported in clinical trial are muscle pain (myalgia), stomach pain, swelling, joint pain (arthralgia), skin redness and rash at the injection site (erythema and pruritis), blood sugar control worsening was observed in patients taking Egrifta and not in patients taking placebo.
Drug Egrifta’s (Tesamorelin) is developed by a Montreal-based pharmaceutical company Theratechnologies Inc. and it is marketed in the U.S. by Rockland, Mass.-based EMD Serono
Do you know now this website has become a most popular and most referred website in pharmaceutical industry and pharmaceutical companies and pharmaceutical manufacturers from all over the world ,for almost all topics related to Pharmaceutical Manufacturing , Pharmaceutical Regulatory Affairs and Good Manufacturing Practice for Pharmaceutical Manufacturing (c GMP guidelines ) and latest news and new drugs developments.
You may also like following articles
What is a Site Master file of a pharmaceutical company
What is Generic Drug
What is Reference Listed Drug ? ( RLD )
What is Pharmaceutical Equivalents
What is Pharmaceutical Alternatives
What is Therapeutic Equivalents
What are Post Market studies
Why a drug is bound to protein, What is protein binding? What is drug absorption , distribution ?
Do Physical properties contribute to drug activity.
What is drug receptor , How a drug resistance occurs
Drug interaction, and its examples
What is first pass metabolism of a drug
What is What is 510(k) Clearances ?
Premarket Notification for medical devices – PMN or 510(k)
Antibiotic Definition and classification
Antibiotic Resistance and Antibiotic resistance mechanism
Vitamin D Details on FDA cautions on accurate dosage of Vitamin D
What is an antibody? what is monoclonal and polyclonal antibodies?
Terminologies In vaccine Production
Multi stage testing of Virus vaccine production
Testing of vaccines at different stages of production
TESTING FOR ADVENTITIOUS AGENTS CELL PROPERTIES IN VIRAL VACCINE PRODUCTION
Enzyme linked immunosorbent assay ELISA
Pharmaceutical Aseptic Manufacturing Process Terms , Terminology and Definitions.
Here are some articles which will be useful for you in further understanding of aspects of sterile dosage form manufacturing and regulatory affairs and good manufacturing practice in
Types of validations in pharmaceutical manufacturing
Requirements of documents for validation of sterilisation process
How to investigate OOS out of specification results
Determination of Phenol coefficient of a disinfectant
Time limitations in sterile pharmaceuticals processing
Aspects of validation of manufacturing process in sterile pharmaceuticals
Requirements of US FDA Inspections of Clinical Investigators of Clinical Trials
PROCEDURE OF AN INSPECTIONS OF CLINICAL TRIAL INVESTIGATOR BY US FDA HOW ARE CLINICAL INVESTIGATOR INSPECTIONS CONDUCTED?
US FDA INSPECTION OF CLINICAL INVESTIGATORS OUT OF UNITED STATES OF AMERICA
REPORTS AFTER AN INSPECTION OF A INVESTIGAOTR OF CLINICAL TRIALS
Controlling Pyrogens in injectable dosage forms
Media fill run process simulation aspects Validation of Aseptic Process and Sterilisation
New Drug Application (NDA) how to make a New Drug Application (NDA) to US FDA
Abbreviated New Drug Application (ANDA) What is ANDA , detailed information about ANDA preparation and submission to US FDA
How to make Investigational New Drug (IND) Application to US FDA
Drug applications submission to us fda Over the counter Drugs OTC drugs
BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS
Electronic record in pharmaceutical manufacturing industry
Good manufacturing practice in pharmaceutical industry
Pharmaceutical industry pharmaceutical companies and FDA latest updates
Here is an interesting article on world wide pharmaceutical industry and making a carrier in one of pharmaceutical companies article on Pharmaceutical Industry pharmaceutical industry
Find a Job in Pharmaceutical Company –>JOBS IN PHARMA INDUSTRY<—
To Find Pharmaceutical jobs and make a Pharmaceutical careers see here pharmaceutical companies
Here are some interesting articles on Quality assurance systems for pharmaceutical company
Quality assurance in pharma industry
Quality by design concept for pharmaceutical industry
Quality by design concept in pharmaceutical industryan explanation
Useful Books For Pharmaceutical Manufacturers and Pharmaceutical Professionals